SunWay Biotech Co., LTD. (TPEX:1271)
Taiwan · Delayed Price · Currency is TWD 59.90
-1.00 (-1.64%)
Aug 19, 2026, 9:35 AM CST
SunWay Biotech Co., LTD. Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,535 | 993.3 | 970.18 | 571.11 | 425.35 | 380.43 |
Revenue Growth | 54.55% | 2.38% | 69.88% | 34.27% | 11.81% | 20.97% |
Gross Profit Gross Profit Growth | 719.69 | 560.5 | 545.04 | 236.67 | 149.89 | 271.11 |
Operating Income Operating Income Growth | 96.16 | 104.13 | 140.98 | 52.1 | 39.23 | 167.29 |
Net Income Net Income Growth | 136.71 | 101.5 | 118.57 | 46.09 | 30.04 | 168.76 |
Earnings Per Share EPS Growth | 2.20 | 1.68 | 1.96 | 1.50 | 1.48 | 4.92 |
EPS Growth | 30.89% | -14.29% | 30.26% | 1.33% | -69.80% | 26.90% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 964.98 | 964.98 | 949.8 | 570.88 | 425.35 | 372.87 |
Americas Americas Growth | 5.49 | 5.49 | 10.79 | - | - | - |
Europe Europe Growth | 12.1 | 12.1 | 4.26 | - | - | - |
Other Other Growth | 10.73 | 10.73 | 5.33 | 0.23 | - | 7.56 |
Total Total Growth | 993.3 | 993.3 | 970.18 | 571.11 | 425.35 | 380.43 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 726.41 | 301.02 | 293.71 | 362.19 | 123.57 | 346.44 |
Total Debt Total Debt Growth | 1,529 | 884.73 | 243.99 | 287.35 | 71.01 | 2.51 |
Net Cash (Debt) Net Cash Growth | -802.55 | -583.7 | 49.71 | 74.84 | 52.57 | 343.93 |
Net Cash Growth | - | - | -33.57% | 42.37% | -84.72% | 17.42% |
Net Cash Per Share Net Cash Per Share Growth | -12.93 | -9.68 | 0.82 | 2.44 | 2.60 | 10.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 159.77 | 222.89 | 156.92 | 55.98 | 42.58 | 160.76 |
Capital Expenditures CapEx Growth | -197.77 | -101.64 | -116.19 | -46.24 | - | -9.71 |
Free Cash Flow Free Cash Flow Growth | -38 | 121.25 | 40.73 | 9.75 | 42.58 | 151.05 |
Free Cash Flow Growth | - | 197.70% | 317.89% | -77.11% | -71.81% | -16.22% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 46.88% | 56.43% | 56.18% | 41.44% | 35.24% | 71.26% |
Operating Margin | 6.26% | 10.48% | 14.53% | 9.12% | 9.22% | 43.97% |
Pretax Margin | 9.88% | 11.62% | 14.65% | 9.79% | 9.32% | 44.74% |
Profit Margin | 8.91% | 10.22% | 12.22% | 8.07% | 7.06% | 44.36% |
FCF Margin | -2.48% | 12.21% | 4.20% | 1.71% | 10.01% | 39.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 1.330 | 0.983 | 3.186 | 4.278 |
Dividend Per Share Growth | -41.19% | -24.81% | 35.24% | -69.14% | -25.52% | 55.36% |
Dividend Yield | 1.69% | 1.71% | 1.76% | 0.78% | 7.56% | 8.46% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 27.70 | 35.34 | 39.88 | 99.10 | 53.19 | 12.10 |
P/FCF Ratio | - | 29.59 | 116.10 | 468.66 | 37.52 | 13.51 |
PS Ratio | 2.40 | 3.61 | 4.87 | 8.00 | 3.76 | 5.37 |